BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 22793067)

  • 1. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells attenuate rat graft-versus-host disease.
    Fujino M; Zhu P; Kitazawa Y; Chen JM; Zhuang J; Li XK
    Methods Mol Biol; 2014; 1213():341-53. PubMed ID: 25173396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.
    Sudres M; Norol F; Trenado A; Grégoire S; Charlotte F; Levacher B; Lataillade JJ; Bourin P; Holy X; Vernant JP; Klatzmann D; Cohen JL
    J Immunol; 2006 Jun; 176(12):7761-7. PubMed ID: 16751424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y; Deng YB; Huang YJ; Wang Y
    Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
    Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
    Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells administered after liver transplantation prevent acute graft-versus-host disease in rats.
    Xia X; Chen W; Ma T; Xu G; Liu H; Liang C; Bai X; Zhang Y; He Y; Liang T
    Liver Transpl; 2012 Jun; 18(6):696-706. PubMed ID: 22344929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report.
    Zhou H; Guo M; Bian C; Sun Z; Yang Z; Zeng Y; Ai H; Zhao RC
    Biol Blood Marrow Transplant; 2010 Mar; 16(3):403-12. PubMed ID: 19925878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
    Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
    Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation.
    Maitra B; Szekely E; Gjini K; Laughlin MJ; Dennis J; Haynesworth SE; Koç ON
    Bone Marrow Transplant; 2004 Mar; 33(6):597-604. PubMed ID: 14716336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model.
    Inoue S; Popp FC; Koehl GE; Piso P; Schlitt HJ; Geissler EK; Dahlke MH
    Transplantation; 2006 Jun; 81(11):1589-95. PubMed ID: 16770249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Flk-1+Sca-1- mesenchymal stem cells: functional plasticity in vitro and immunoregulation in vivo.
    Xishan Z; Haojun Y; Baoxin H; Xinna Z; Ni J; Hongmei Z; Xiaoli W; Jun R
    Transplantation; 2014 Mar; 97(5):509-17. PubMed ID: 24487394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease.
    Bruck F; Belle L; Lechanteur C; de Leval L; Hannon M; Dubois S; Castermans E; Humblet-Baron S; Rahmouni S; Beguin Y; Briquet A; Baron F
    Cytotherapy; 2013 Mar; 15(3):267-79. PubMed ID: 23265769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
    Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
    Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.
    Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X
    Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.